Short-term outcomes after pancreatoduodenectomy in octogenarians: multicentre case-control study.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
17 12 2021
Historique:
received: 29 12 2020
accepted: 28 09 2021
pubmed: 10 11 2021
medline: 9 2 2022
entrez: 9 11 2021
Statut: ppublish

Résumé

Pancreatoduodenectomy (PD) is frequently the surgical treatment indicated for a number of pathologies. Elderly patients may be denied surgery because of concerns over poor perioperative outcomes. The aim of this study was to evaluate postoperative clinical outcomes and provide evidence on current UK practice in the elderly population after PD. This was a multicentre retrospective case-control study of octogenarians undergoing PD between January 2008 and December 2017, matched with younger controls from seven specialist centres in the UK. The primary endpoint was 90-day mortality. Secondary endpoints were index admission mortality, postoperative complications, and 30-day readmission rates. In total, 235 octogenarians (median age 81 (range 80-90) years) and 235 controls (age 67 (31-79) years) were included in the study. Eastern Cooperative Oncology Group performance status (median 0 (range 0-3) versus 0 (0-2); P = 0.010) and Charlson Co-morbidity Index score (7 (6-11) versus 5 (2-9); P = 0.001) were higher for octogenarians than controls. Postoperative complication and 30-day readmission rates were comparable. The 90-day mortality rate was higher among octogenarians (9 versus 3 per cent; P = 0.030). Index admission mortality rates were comparable (4 versus 2 per cent; P = 0.160), indicating that the difference in mortality was related to deaths after hospital discharge. Despite the higher 90-day mortality rate in the octogenarian population, multivariable Cox regression analysis did not identify age as an independent predictor of postoperative mortality. Despite careful patient selection and comparable index admission mortality, 90-day and, particularly, out-of-hospital mortality rates were higher in octogenarians.

Sections du résumé

BACKGROUND
Pancreatoduodenectomy (PD) is frequently the surgical treatment indicated for a number of pathologies. Elderly patients may be denied surgery because of concerns over poor perioperative outcomes. The aim of this study was to evaluate postoperative clinical outcomes and provide evidence on current UK practice in the elderly population after PD.
METHODS
This was a multicentre retrospective case-control study of octogenarians undergoing PD between January 2008 and December 2017, matched with younger controls from seven specialist centres in the UK. The primary endpoint was 90-day mortality. Secondary endpoints were index admission mortality, postoperative complications, and 30-day readmission rates.
RESULTS
In total, 235 octogenarians (median age 81 (range 80-90) years) and 235 controls (age 67 (31-79) years) were included in the study. Eastern Cooperative Oncology Group performance status (median 0 (range 0-3) versus 0 (0-2); P = 0.010) and Charlson Co-morbidity Index score (7 (6-11) versus 5 (2-9); P = 0.001) were higher for octogenarians than controls. Postoperative complication and 30-day readmission rates were comparable. The 90-day mortality rate was higher among octogenarians (9 versus 3 per cent; P = 0.030). Index admission mortality rates were comparable (4 versus 2 per cent; P = 0.160), indicating that the difference in mortality was related to deaths after hospital discharge. Despite the higher 90-day mortality rate in the octogenarian population, multivariable Cox regression analysis did not identify age as an independent predictor of postoperative mortality.
CONCLUSION
Despite careful patient selection and comparable index admission mortality, 90-day and, particularly, out-of-hospital mortality rates were higher in octogenarians.

Identifiants

pubmed: 34750618
pii: 6423586
doi: 10.1093/bjs/znab374
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-95

Informations de copyright

© Crown copyright 2021.

Auteurs

Joseph A Attard (JA)

Hepatopancreatobiliary and Liver Transplant Unit, Queen Elizabeth Hospital, Birmingham, UK.

Bilal Al-Sarireh (B)

Department of Surgery, Morriston Hospital, Swansea, UK.

Ricky Harminder Bhogal (RH)

Hepatopancreatobiliary Unit, Royal Marsden Hospital, London, UK.

Alexia Farrugia (A)

Department of Surgery, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Giuseppe Fusai (G)

Hepatopancreatobiliary and Liver Transplant Unit, Royal Free Hospital, London, UK.

Simon Harper (S)

Hepatopancreatobiliary Unit, Cambridge University Hospital, Cambridge, UK.

Camila Hidalgo-Salinas (C)

Hepatopancreatobiliary and Liver Transplant Unit, Royal Free Hospital, London, UK.

Asif Jah (A)

Hepatopancreatobiliary Unit, Cambridge University Hospital, Cambridge, UK.

Gabriele Marangoni (G)

Department of Surgery, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Matthew Mortimer (M)

Department of Surgery, Morriston Hospital, Swansea, UK.

Michail Pizanias (M)

Hepatopancreatobiliary Unit, King's College Hospital, London, UK.

Andreas Prachialias (A)

Hepatopancreatobiliary Unit, King's College Hospital, London, UK.

Keith J Roberts (KJ)

Hepatopancreatobiliary and Liver Transplant Unit, Queen Elizabeth Hospital, Birmingham, UK.

Chloe Sew Hee (C)

Hepatopancreatobiliary Unit, Cambridge University Hospital, Cambridge, UK.

Fiammetta Soggiu (F)

Hepatopancreatobiliary and Liver Transplant Unit, Royal Free Hospital, London, UK.

Parthi Srinivasan (P)

Hepatopancreatobiliary Unit, King's College Hospital, London, UK.

Nikolaos A Chatzizacharias (NA)

Hepatopancreatobiliary and Liver Transplant Unit, Queen Elizabeth Hospital, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH